Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05914246Not ApplicableCompleted

VIOLA Post Market Surveillance Clinical Protocol

Role: lead

NCT03209609Not ApplicableCompleted

VEST Venous Graft External Support Pivotal Study

Role: lead

NCT04003480Not ApplicableSuspended

FRAME, External Support for Lower Limb Autologous Grafts

Role: lead

NCT02511834Not ApplicableCompleted

VEST III PMS Clinical Protocol

Role: lead

NCT02332330Not ApplicableCompleted

CD0104 VEST II Post Marketing Surveillance Study

Role: lead

NCT01415245Not ApplicableCompleted

Vein External Support Trial

Role: lead

All 6 trials loaded